A new blood coagulation inhibitor from the snake Bothrops jararaca plasma: Isolation and characterization

Biochemical and Biophysical Research Communications

Volumn 308, Issue 4, 2003, Pages 706-712

  Tanaka Azevedo, Anita M ^a   Tanaka, Aparecida S ^b   Sano Martins, Ida S ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood; Blood coagulation; Bothrops jararaca; Enzyme inhibitor; Protein characterization; Protein purification; Reptiles; Snake blood; Snake plasma; Thrombin inhibitor

Indexed keywords

BOTHROPS JARARACA INHIBITOR; THROMBIN INHIBITOR; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; BINDING AFFINITY; BLOOD; BLOOD CLOTTING; CHROMATOGRAPHY; DISULFIDE BOND; DRUG ACTIVITY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG PURIFICATION; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SNAKE; THROMBOCYTE; THROMBOCYTE AGGREGATION;

BOTHROPS; BOTHROPS JARARACA; REPTILIA; SERPENTES;

EID: 0042661154     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01464-5     Document Type: Article

References (29)

1. Davie E.W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance and regulation. Biochemistry. 30:1991;10363-10370.
2. Stubbs M.T., Bode W. A player of many parts: the spotlight falls on thrombin's structure. Thromb. Res. 69:1993;1-58.
3. Fenton J.W., Ofosu F.A., Moon D.G., Maraganore J.M. Thrombin structure and function: why thrombin is the primary target for antithrombotics. Blood Coagul. Fibrinolysis. 2:1991;69-75.
4. Stubbs M.T., Bode W. The clot thickens: clues provided by thrombin structure. Trends Biochem. Sci. 20:1995;23-28.
5. Nahas L., Kamiguti S., Betti F., Sano-Martins I.S., Rodrigues M.I. Blood coagulation mechanism in the snakes Waglerophis merremii and Bothrops jararaca. Comp. Biochem. Physiol. 69A:1981;739-743.
6. Didisheim P., Kenichi H., Lewis J.N. Hematologic and coagulation studies in various animal species. J. Lab. Clin. Med. 53:1959;866.
7. Fantl P. A comparative study of blood coagulation in vertebrates. Aust. J. Exp. Biol. Med. Sci. 39:1961;403-412.
8. Hachett E., Hann C. Slow clotting of reptile blood. J. Comp. Pathol. 77:1967;175-180.
9. Nahas L., Betti F., Kamiguti A.S., Sato H. Blood coagulation inhibitor in a snake plasma (Bothrops jararaca). Thrombos. Diathes. Haemorrh. 30:1973;106-113.
10. Bode W., Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur. J. Biochem. 204:1992;433-451.
11. Stone S.R., Tapparelli C. Thrombin inhibitors an antithrombotic agents: the importance of rapid inhibition. J. Enzyme Inhib. 9:1995;3-15.
12. Gulba D.C., Bode C., Runge M.S., Huber K. Thrombolytic agents: an updated overview. Fibrin. Proteol. 12:1998;39-58.
13. Stoscheck C.M. Quantification of protein. Meth. Enzymol. 182:1990;50-68.
14. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
15. Timmons S., Hawiger J. Isolation of human platelets by albumin gradient and gel filtration. Meth. Enzymol. 169A:1989;11-21.
16. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927-929.
17. Frantzen H.G., Abildgaard U., Aasen A.O. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Scand. J. Haematol. 31:1983;427-436.
18. 2 macroglobulin-like proteinase inhibitor from plasma of the crayfish Pacifastacus leniusculus Biochem. J. 255:1988;801-806.
19. Grutter M.G., Priestle J.P., Rahuel J., Grossenbacher H., Boce W., Hofsteenge J., Stone S.R. Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J. 9:1990;2361-2365.
20. Mao S.J., Yates M.T., Owen T.J., Krstenansky J.L. Interaction of hirudin with thrombin: identification of a minimal binding domain of hirudin that inhibits clotting activity. Biochemistry. 27:1988;8170-8173.
21. Maraganore J.M., Chao B., Joseph M.L., Jablonski J., Ramachandran K.L. J. Biol. Chem. 265:1989;8692-8698.
22. Zingali R.B., Jandrot-Perrus M., Guillin M.-D., Bon C. Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition. Biochemistry. 32:1993;10794-10802.
23. Lombardi A., Simone G.D., Galdiero S., Staiano N., Nastri F., Pavone V. From natural to synthetic multisite thrombin inhibitors. Biopolymers (Peptide Science). 51:1999;19-39.
24. Bode W., Turk D., Karshikov A. The refined 1.9 A X-ray crystal structure of D-Phe-Pro-Arg-chloromethylketone-inhibited human α-thrombin: structure analysis, overall structure, electrostatic properties detailed active-site geometry, and structure-function relationships. Protein Sci. 1:1992;426-471.
25. Arni R.K., Padmanabhan K., Padmanabhan K.P., Wu T.P., Tulinsky A. Structure of the noncovalent complexes of human and bovine fragment 2 with human PPACK-thrombin. Biochemistry. 32:1993;4727-4737.
26. Liu L.W., Rezaie A.R., Carson C.W., Esmon N.L., Esmon C.T. Occupancy of anion binding exosite 2 on thrombin determines Ca2+ dependence of protein C activation. J. Biol. Chem. 269:1994;11807-11812.
27. Bock P.E. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases. J. Biol. Chem. 267:1992;14974-14981.
28. II Fenton J.W., Olson T.A., Zabinski M.P., Wilner G.D. Anion binding exosite of human thrombin and fibrin(ogen) recognition. Biochemistry. 27:1988;7106-7112.
29. White G.C., Lundblad R.L., Griffith M.J. Structure-function relations in platelet-thrombin reactions. J. Biol. Chem. 256:1981;1763-1766.